Recombinant multi-species RPL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL15 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of four RNA species and approximately 80 structurally distinct proteins. This gene encodes a member of the L15E family of ribosomal proteins and a component of the 60S subunit. This gene shares sequence similarity with the yeast ribosomal protein YL10 gene. Elevated expression of this gene has been observed in esophageal tumors and gastric cancer tissues, and deletion of this gene has been observed in a Diamond-Blackfan anemia (DBA) patient. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Mar 2017]
The Alternative Names of target: 2510008H07Rik,60S ribosomal protein L15,DBA12,EC45,L15,Large ribosomal subunit protein eL15,RPL10,RPL15,RPLY10,RPYL10,Rpl10,Rpl15,eL15

Target products collectionGo to RPL15 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T73230-Ag-1/ GM-Tg-hg-T73230-Ag-2 Human RPL15 protein Human
GM-Tg-rg-T73230-Ag-1/ GM-Tg-rg-T73230-Ag-2 Rat RPL15 protein Rat
GM-Tg-mg-T73230-Ag-1/ GM-Tg-mg-T73230-Ag-2 Mouse RPL15 protein Mouse
GM-Tg-cynog-T73230-Ag-1/ GM-Tg-cynog-T73230-Ag-2 Cynomolgus/Rhesus macaque RPL15 protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T73230-Ag-1/ GM-Tg-felg-T73230-Ag-2 Feline RPL15 protein Feline
GM-Tg-cang-T73230-Ag-1/ GM-Tg-cang-T73230-Ag-2 Canine RPL15 protein Canine
GM-Tg-bovg-T73230-Ag-1/ GM-Tg-bovg-T73230-Ag-2 Bovine RPL15 protein Bovine
GM-Tg-equg-T73230-Ag-1/ GM-Tg-equg-T73230-Ag-2 Equine RPL15 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T73230-Ag-1/ GM-Tg-hg-T73230-Ag-2; GM-Tg-rg-T73230-Ag-1/ GM-Tg-rg-T73230-Ag-2;
GM-Tg-mg-T73230-Ag-1/ GM-Tg-mg-T73230-Ag-2; GM-Tg-cynog-T73230-Ag-1/ GM-Tg-cynog-T73230-Ag-2;
GM-Tg-felg-T73230-Ag-1/ GM-Tg-felg-T73230-Ag-2; GM-Tg-cang-T73230-Ag-1/ GM-Tg-cang-T73230-Ag-2;
GM-Tg-bovg-T73230-Ag-1/ GM-Tg-bovg-T73230-Ag-2; GM-Tg-equg-T73230-Ag-1/ GM-Tg-equg-T73230-Ag-2
Products Name RPL15 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name RPL15
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine RPL15 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.